Application of Nanotechnology in Therapeutic Cancer Vaccines
Cancer vaccines stimulate the immune system within the body by introducing tumor antigens in various forms, such as tumor cells, tumor‐related proteins or peptides, and genes expressing tumor antigens, into the body. This activation of the immune response aims to prevent or treat tumors. Preventive...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley-VCH
2023-07-01
|
| Series: | Advanced NanoBiomed Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/anbr.202200122 |
| _version_ | 1797785511461388288 |
|---|---|
| author | Jianmei Guo Lin Tang Kelin Li Qingxin Ma Shuda Luo Ruoyu Cheng Chaoyong Liu |
| author_facet | Jianmei Guo Lin Tang Kelin Li Qingxin Ma Shuda Luo Ruoyu Cheng Chaoyong Liu |
| author_sort | Jianmei Guo |
| collection | DOAJ |
| description | Cancer vaccines stimulate the immune system within the body by introducing tumor antigens in various forms, such as tumor cells, tumor‐related proteins or peptides, and genes expressing tumor antigens, into the body. This activation of the immune response aims to prevent or treat tumors. Preventive cancer vaccines are primarily targeted at cancers caused by viral infections, and most cancer vaccines are currently designed as therapeutic vaccines for cancer treatment. In this review, the development of cancer vaccines, the mechanism of action, the types of antigens, and the progress of nanotechnology in therapeutic cancer vaccines are summarized. The development and application of cancer vaccines incorporating tumor‐specific antigens and nanomaterials are anticipated. |
| first_indexed | 2024-03-13T00:55:07Z |
| format | Article |
| id | doaj.art-57b1a771621c47bdaa7d6708f17ab695 |
| institution | Directory Open Access Journal |
| issn | 2699-9307 |
| language | English |
| last_indexed | 2024-03-13T00:55:07Z |
| publishDate | 2023-07-01 |
| publisher | Wiley-VCH |
| record_format | Article |
| series | Advanced NanoBiomed Research |
| spelling | doaj.art-57b1a771621c47bdaa7d6708f17ab6952023-07-07T02:00:40ZengWiley-VCHAdvanced NanoBiomed Research2699-93072023-07-0137n/an/a10.1002/anbr.202200122Application of Nanotechnology in Therapeutic Cancer VaccinesJianmei Guo0Lin Tang1Kelin Li2Qingxin Ma3Shuda Luo4Ruoyu Cheng5Chaoyong Liu6College of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaBeijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCollege of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCollege of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCollege of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCollege of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCollege of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 P.R. ChinaCancer vaccines stimulate the immune system within the body by introducing tumor antigens in various forms, such as tumor cells, tumor‐related proteins or peptides, and genes expressing tumor antigens, into the body. This activation of the immune response aims to prevent or treat tumors. Preventive cancer vaccines are primarily targeted at cancers caused by viral infections, and most cancer vaccines are currently designed as therapeutic vaccines for cancer treatment. In this review, the development of cancer vaccines, the mechanism of action, the types of antigens, and the progress of nanotechnology in therapeutic cancer vaccines are summarized. The development and application of cancer vaccines incorporating tumor‐specific antigens and nanomaterials are anticipated.https://doi.org/10.1002/anbr.202200122cancer vaccinesclinical trialsnanotechnologytherapeutictumor-specific antigens |
| spellingShingle | Jianmei Guo Lin Tang Kelin Li Qingxin Ma Shuda Luo Ruoyu Cheng Chaoyong Liu Application of Nanotechnology in Therapeutic Cancer Vaccines Advanced NanoBiomed Research cancer vaccines clinical trials nanotechnology therapeutic tumor-specific antigens |
| title | Application of Nanotechnology in Therapeutic Cancer Vaccines |
| title_full | Application of Nanotechnology in Therapeutic Cancer Vaccines |
| title_fullStr | Application of Nanotechnology in Therapeutic Cancer Vaccines |
| title_full_unstemmed | Application of Nanotechnology in Therapeutic Cancer Vaccines |
| title_short | Application of Nanotechnology in Therapeutic Cancer Vaccines |
| title_sort | application of nanotechnology in therapeutic cancer vaccines |
| topic | cancer vaccines clinical trials nanotechnology therapeutic tumor-specific antigens |
| url | https://doi.org/10.1002/anbr.202200122 |
| work_keys_str_mv | AT jianmeiguo applicationofnanotechnologyintherapeuticcancervaccines AT lintang applicationofnanotechnologyintherapeuticcancervaccines AT kelinli applicationofnanotechnologyintherapeuticcancervaccines AT qingxinma applicationofnanotechnologyintherapeuticcancervaccines AT shudaluo applicationofnanotechnologyintherapeuticcancervaccines AT ruoyucheng applicationofnanotechnologyintherapeuticcancervaccines AT chaoyongliu applicationofnanotechnologyintherapeuticcancervaccines |